James A. Boiani, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was quoted in FDA Week, in “Device Lawyer: FDA Guidances Provide Clarity on Payer Communication,” by David Roza. (Read the full version – subscription required.)

Following is an excerpt:

A device industry lawyer applauded the release of two FDA guidances that he said provide long-awaited clarity for device manufacturers on how they can communicate health care economic information (HCEI) and certain off-label information about FDA-approved or cleared devices to payers. The guidance, the lawyer says, serves to define FDA-approved ways for sharing such information, which could encourage more companies to communicate that information with payers.

James Boiani, a member of Epstein Becker & Green’s Health Care and Life Sciences practice, said his clients have been waiting for these guidances since enactment of the Food and Drug Administration Modernization Act (FDAMA) of 1997. FDAMA section 114 allows manufactures to disseminate information about off-label uses of drugs and medical devices and lets drug companies provide economic information about their products to formulary committees, managed care organizations and large-scale buyers of health care products.

“Just the fact that they released [the guidances] is helpful, this is an issue a lot of my clients have struggled with since the provision was put into law,” Boiani said. “It’s been out there for a long time and this is certainly the most comprehensive guidance we’ve had.” …

The lawyer said the main takeaway from the guidance is that device makers must be “exceedingly clear” about which uses for a device are on label and which are not when communicating with payers. Providing an FDA roadmap on the matter could help more companies communicate with payers more regularly, he said.

“I think in a sense it gives them an accepted pathway for communicating that information,” Boiani said. “Some device makers communicate information more aggressively than others, and this provides FDA’s thinking and levels the playing field.”

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.